|
EUPATI CH is now officially a Swiss Association!
PACRT was a founding member on the committee of the Swiss National Liaison Team of the European Patient Academy for Therapeutic Innovation (EUPATI) http://www.patientsacademy.eu/index.php/en/nationalplatforms EUPATI aims to empower patients by providing scientifically reliable, objective, comprehensive information on medicines research and development. Please note that while EUPATI is not focused on cancer nor is it disease specify, it will increase the capacities and capablitities of patients and patient organizations to be effective advocates and advisors in medicines research, e.g. with clinical trials, with regulatory authorities and in ethics committees -- which is a goal in common with PACRT. PACRT teamed up to support Geraldine Canny, PhD, who is the focalpoint for the organizing activities of EUAPTI in the French-Speaking part of Switzerland. Together we organized a meeting on Wednesday, 25 March, 2015, 2-5pm, in Lausanne, to introduce the EUPATI concept and connect interested stakeholders in the Swiss Lémanic Arc. The event was held in English and French, according to the language preference of the individual. The full launch of EUPATI Switzerland (spanning the entire country) took take place Wednesday, 3 February, 2016, hosted with support of EUPATI and the Swiss Clinical Trials Organization in Bern. |
Welcome!
Welcome to the website of Patient Advocates for Cancer Research and Treatment (PACRT), an independent, non-profit, volunteer-based public interest organization, founded by a Swiss-American breast cancer survivor, based in Geneva, Switzerland.
The goal of PACRT is to bring patients into the center in all aspects of cancer research and treatment to improve solutions ("Anything About us, With us!") and enhance patient empowerment in Switzerland.
PACRT works in partnership with patient organizations, researchers/academicians, clinicians, public health, and others in the Swiss healthcare system to empower cancer patients by contributing to the best cancer research, and improving prevention, diagnosis, care, treatment, and technology for quality living.